References
- Lokich J. Spontaneous regression of metastatic renal cancer: Case report and literature review. Am J Clin Oncol 1997; 20: 416–8
- Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol 2005; 23: 1028–43
- Medical Research Council Renal Cancer Collaborators. Interferon-alpha and survival in metastatic renal carcinoma: Early results of a randomised controlled trial. Lancet 1999;353:14–7.
- Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Fyfe G. High-dose aldesleukin in renal cell carcinoma: Long-term survival update. Cancer J Sci Am 1997; 3: S70–S72
- Yun T, Lee KW, Song EG, Na II, Shin HC, Yoon SS, et al. Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma. Clin Transplant 2007; 21: 337–43
- Gabrilovich DI, Chen HL, Girgis KR, Cunningham T, Meny GM, Nadaf S, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996; 2: 1096–103
- Sabat R, Philipp S, Hoflich C, Kreutzer S, Wallace E, Asudullah K, et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16: 779–98
- Thonhofer R, Gaugg M, Kriessmayr M, Neumann HJ, Erlacher L. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Ann Rheum Dis 2005; 64: 1098–9
- Matsushita T, Hasegawa M, Shirasaki F, Fujimoto M, Yamazaki H, Sato S, et al. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris. Dermatology 2008; 216: 34–67
- Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 2000; 114: 587–90